Pharmacology Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Pharmacology stocks.

Pharmacology Stocks Recent News

Date Stock Title
Nov 23 JNJ Trump picks surgeon Marty Makary to head FDA, Rep. Dave Weldon to lead CDC
Nov 22 JNJ Layoffs in 2024: A List of Companies Cutting Jobs This Year
Nov 22 CTLT Catalent gains on reports it's likely to be granted EU approval for Novo Holdings deal (update)
Nov 22 JNJ J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis
Nov 22 JNJ Medtronic acquires Fortimedix Surgical to boost surgical portfolio
Nov 22 JNJ Sanofi Plans to Change Hospital Drug-Discount Program
Nov 22 JNJ Health Canada issues NOC to J&J’s CARVYKTI for multiple myeloma
Nov 22 JNJ Johnson & Johnson seeks FDA approval for its ulcerative colitis treatment
Nov 22 JNJ Dividend Roundup: General Mills, Halliburton, Johnson & Johnson, Coca-Cola, and others
Nov 22 JNJ Johnson & Johnson seeks U.S. FDA approval for subcutaneous induction regimen of TREMFYA® (guselkumab) in ulcerative colitis, a first for an IL-23 inhibitor
Nov 22 JNJ Johnson & Johnson (NYSE:JNJ) Stock Goes Ex-Dividend In Just Three Days
Nov 21 JNJ Health Canada Authorizes CARVYKTI® (ciltacabtagene autoleucel) for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received One to Three Prior Lines of Therapy
Nov 21 CTLT Melt reports topline outcomes from trial of MELT-300 for cataract surgery
Nov 20 JNJ Update: Market Chatter: Johnson & Johnson, Merck Cut Jobs in China
Nov 20 CTLT Morgan Stanley lists hedge funds’ largest Q3 ownership increases in Russell 1000 stocks
Nov 19 JNJ Large caps in trouble? Key takeaways from Tommy Tuberville's latest trades
Nov 19 JNJ Johnson & Johnson: Policy Uncertainty Elevated, But Shares Remain Inexpensive
Nov 19 JNJ Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting
Nov 19 JNJ J&J pill clears skin in two late-stage psoriasis studies
Nov 19 JNJ Johnson & Johnson reports topline outcomes from trial of icotrokinra for psoriasis
Pharmacology

Pharmacology is the branch of biology concerned with the study of drug action, where a drug can be broadly defined as any man-made, natural, or endogenous (from within the body) molecule which exerts a biochemical or physiological effect on the cell, tissue, organ, or organism (sometimes the word pharmacon is used as a term to encompass these endogenous and exogenous bioactive species). More specifically, it is the study of the interactions that occur between a living organism and chemicals that affect normal or abnormal biochemical function. If substances have medicinal properties, they are considered pharmaceuticals.
The field encompasses drug composition and properties, synthesis and drug design, molecular and cellular mechanisms, organ/systems mechanisms, signal transduction/cellular communication, molecular diagnostics, interactions, toxicology, chemical biology, therapy, and medical applications and antipathogenic capabilities. The two main areas of pharmacology are pharmacodynamics and pharmacokinetics. Pharmacodynamics studies the effects of a drug on biological systems, and Pharmacokinetics studies the effects of biological systems on a drug. In broad terms, pharmacodynamics discusses the chemicals with biological receptors, and pharmacokinetics discusses the absorption, distribution, metabolism, and excretion (ADME) of chemicals from the biological systems. Pharmacology is not synonymous with pharmacy and the two terms are frequently confused. Pharmacology, a biomedical science, deals with the research, discovery, and characterization of chemicals which show biological effects and the elucidation of cellular and organismal function in relation to these chemicals. In contrast, pharmacy, a health services profession, is concerned with application of the principles learned from pharmacology in its clinical settings; whether it be in a dispensing or clinical care role. In either field, the primary contrast between the two are their distinctions between direct-patient care, for pharmacy practice, and the science-oriented research field, driven by pharmacology.
The origins of clinical pharmacology date back to the Middle Ages in Avicenna's The Canon of Medicine, Peter of Spain's Commentary on Isaac, and John of St Amand's Commentary on the Antedotary of Nicholas. Clinical pharmacology owes much of its foundation to the work of William Withering. Pharmacology as a scientific discipline did not further advance until the mid-19th century amid the great biomedical resurgence of that period. Before the second half of the nineteenth century, the remarkable potency and specificity of the actions of drugs such as morphine, quinine and digitalis were explained vaguely and with reference to extraordinary chemical powers and affinities to certain organs or tissues. The first pharmacology department was set up by Rudolf Buchheim in 1847, in recognition of the need to understand how therapeutic drugs and poisons produced their effects.Early pharmacologists focused on natural substances, mainly plant extracts. Pharmacology developed in the 19th century as a biomedical science that applied the principles of scientific experimentation to therapeutic contexts. Today pharmacologists use genetics, molecular biology, biochemistry, and other advanced tools to transform information about molecular mechanisms and targets into therapies directed against disease, defects or pathogens, and create methods for preventative care, diagnostics, and ultimately personalized medicine.

Browse All Tags